Skip to main content
All lobbying filings

THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

Lobbying for THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $80,000.00 expenses · posted Jul 20, 2026

Official filing document

 Lobbying activity 4
Medicare/Medicaid

All legislation related to Medicare site of service payment policy changes; Any legislation having to do with Medicare payments for dedicated cancer centers and hospitals, including satellite regulations; Medicare Advantage preauthorization; Medicare Advantage access issues; Cuts to services related to cancer diagnosis and treatment; Issues related to increased access to cancer detection. Issues related to "White Bagging" of pharmaceutical products; Policies related to the value of cancer care and initiatives that bend the cost curve; Issue related to site neutral payment reforms; Issues related to the FAIR Act and the work of the joint Taskforce developing a new method of cost reimbursement and federal grants

Budget/Appropriations

Issues related to the President's federal budget request; Funding levels for federal appropriation bills including Labor-HHS-Education, Homeland Security, Department of Defense, Commerce-Justice-Science that are related to biomedical research funding, healthcare delivery, training and education, protection of intellectual property and research. Funding for NIH and NCI.

Government Issues

Issues related to the reorganization of HHS and its underlying agencies: NIH, CDC, CMS, and FDA; Issues relating to clinical trials at FDA and the ability for patients to be able to access trials earlier in their treatment journey;

Medical/Disease Research/Clinical Labs

Issues related to clinical trial design and patients obtaining drugs sooner in the course of the trial

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem